Journal of Pharmaceutical Analysis and Drug Research ISSN: 3108-0839 (Online)

Authors: Dr. Kavita R. Menon, Dr. Arvind S. Bhatia

Abstract : The landscape of pharmaceutical science has been revolutionized by the emergence of novel drug modalities, such as biologics, nucleic acid-based therapies, antibody-drug conjugates (ADCs), cell and gene therapies, and nanomedicines. While these advanced modalities offer remarkable therapeutic potential, they also introduce significant analytical challenges due to their complexity, heterogeneity, and structural instability. Analytical scientists are now required to employ cutting-edge methodologies and interdisciplinary approaches to ensure the safety, efficacy, and consistency of these therapeutics. This paper critically examines the analytical challenges associated with novel drug modalities, exploring issues related to characterization, stability assessment, bioassay development, and regulatory compliance. Furthermore, it discusses the evolving analytical landscape, future prospects, and the need for harmonization in analytical standards for next-generation pharmaceuticals.

Keywords: Novel drug modalities, analytical challenges, biologics, nucleic acid therapeutics, cell and gene therapy, antibody-drug conjugates, nanomedicine, bioanalysis, regulatory science.